Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. - Wikidata - awgldk - TriplyDB

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

http://www.wikidata.org/entity/Q30860069

about

In 2014, can we do better than CA125 in the early detection of ovarian cancer?Serum amyloid A: an acute-phase protein involved in tumour pathogenesis Proteomics and mass spectrometry for cancer biomarker discovery Clinical proteomics and mass spectrometry profiling for cancer detection.Human body fluid proteome analysis.Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.Applications of SELDI-MS technology in oncology Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks.Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.Plasma biomarkers in a mouse model of preterm labor.Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations Phase II biomarker trial of a multimarker diagnostic for ovarian cancer Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring The new platinum-based anticancer agent LA-12 induces retinol binding protein 4 in vivo Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.Protein biomarkers of ovarian cancer: the forest and the trees Proteomic technology for biomarker profiling in cancer: an update Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.Time-of-flight mass spectrometry in screening serum-specific protein in patients with scrotal Paget's disease.Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Challenges for molecular profiling of chronic fatigue syndrome.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Dual effect of serum amyloid A on the invasiveness of glioma cells.Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.Ovarian cancer: biomarker proteomic diagnosis in progress.Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications.Contrasting increased levels of serum amyloid A in patients with three different bone sarcomas: An indicator of tumor malignancy?SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.Exploring the expression bar code of SAA variants for gastric cancer detection.Serum amyloid a protein in clinical cancer diagnosis.Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery Creation of Individual Scientific Concept-Centered Semantic Maps Based on Automated Text-Mining Analysis of PubMed

P2860

Q26825152-F8330BA4-3F1F-4569-BC67-C50BFF99FDEE Q28291806-DCBA3EAE-CFE2-4016-8F0D-BFE3452D16FD Q28766969-55CC3957-A866-4143-B2E3-23DCFCF8E289 Q33246668-731AD56D-E0D4-488D-9ED0-0224CC0A5669 Q33262623-165E5282-3E4F-45BF-84D3-4B278BF5A030 Q33301709-56270C87-AAF8-435B-91AF-D3ADB17BDC32 Q33319301-5A50F0A5-9C39-4016-B4F3-89F6DFC8AA1E Q33322964-7DF6A4F3-1710-4D7A-AA08-48BFCEF928AC Q33338626-9CDA6544-B8A9-4FE6-9480-340B6699D9A5 Q33344488-32018FAB-B391-47D6-B36C-D099995F00E2 Q33418258-7DB6E0C1-C58D-4D5F-A3F2-9BF9AD50660E Q33584262-C56C4630-5BEC-44F3-AFA9-798A71274D62 Q33868802-FDFC9103-B6D3-417F-96B5-D6716F83D4D0 Q33945104-35DCBE7F-A1AC-4DA1-A565-FAA7012D2B01 Q33990542-7E0BAB82-4592-455D-B77E-9D0FEDF90923 Q34062814-EBA90F3B-AB4B-442E-B1EC-B701D154071C Q34097044-249E38B9-E4B3-4A95-AD52-4551E519256F Q34216967-57A9592F-2A1E-4BF7-8276-362FB5F123EA Q34324615-6659DEA0-B89E-46D1-BD89-8126C5978DFF Q34634143-30BF1E90-F001-4409-8AF2-096859494E09 Q34657835-319AACFE-573C-4299-9208-021E3AD9554A Q34893763-356C391A-E35E-4D4D-865F-A060A112BF93 Q34961484-5B72DF1B-2571-4B4C-9E36-A4B72D27C955 Q35118218-73C8B02E-190F-436B-B9C6-BF7E43C189C2 Q35995489-A8A5FC46-4C33-4FAD-A2AD-A22F68BCA65D Q36147848-339827BE-0826-4142-A6C0-1692423A6983 Q36412667-69853518-2B61-4597-93C3-77C953D5704E Q36582422-BB96955A-9ABF-44E6-BB80-6A7E76DBEC64 Q36682802-F3A73CCD-D3BA-4186-BC9A-92293D5D956C Q36686826-24F05B22-0FA0-4160-8178-69269C498A4C Q37340624-635218B9-9A88-45B6-8387-8DB91BCF7AAB Q37484011-A473A52F-657A-4B17-A0E5-4F1C82E4999A Q38040333-5EDBD827-A5D0-423C-BE9F-01F646F252C2 Q38947233-4DA66572-B546-453C-99B7-19CFF5FC5623 Q43672699-A845A500-A5A8-47E8-85B9-6076492ED5AA Q44144829-8E6A05A7-9C66-4072-A43C-5BB367D5E07C Q48158874-1E40A246-D18F-488E-B77B-D2A03B321F14 Q53282038-3085F62C-132E-4F3F-A229-E28778927428 Q57173976-BD01FA52-A594-421C-AC69-65A6E3C34F86 Q57174481-0D4386EE-CB02-4E05-97C9-153B757528B3

P2860

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

http://www.wikidata.org/entity/Q30860069

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@ast

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@en

type

label

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@ast

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@en

prefLabel

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@ast

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@en

P1433

Q30860069-9AFCB7B5-7176-4ED8-9E6B-19C944894C26

P1476

Q30860069-35FD660A-0302-4885-A607-268C0517022E

P2093

Q30860069-06427407-864F-432B-AB87-FC163653767F

Q30860069-3EA932B9-781B-4D87-855B-D35BD38E4247

Q30860069-6C6A1AF2-34B2-483A-98E1-6800ADF05F45

Q30860069-7D9F1B81-6215-4450-8597-CAC4F57252B5

Q30860069-A1AC1BB1-D626-4B77-AF13-12A7E5856A11

Q30860069-C5357FE5-DFE2-49B0-BBD2-1D78B092A1FD

Q30860069-ED31916F-1516-4520-971D-88771F40BDB5

P304

Q30860069-84AA979C-77D1-4E42-8F2B-99DE7F27400E

P31

Q30860069-C778132F-D709-4393-A1F2-B4C35382CDD2

P356

Q30860069-75161518-6A42-4A5D-BDAD-491137247DAE

P433

Q30860069-07A36E25-B839-4333-967A-28C1EED4921B

P478

Q30860069-EE8368F2-C22D-4480-A249-2D6ADA8A568C

P50

Q30860069-003CB328-A17A-4710-88A9-8C4C9DF0BFF3

Q30860069-ABAED0D3-6265-4927-BF40-E2A1EDA8EC66

P577

Q30860069-EE003A2F-A375-44D3-8D33-F951A741FC89

P5875

Q30860069-097BEBD2-A160-42D7-999D-CD56ACFC2EE4

P698

Q30860069-F33967CE-8423-4A12-9F15-DFF752B36242

P921

Q30860069-09830309-3BC0-4455-AFAD-D7D1BC2CC039

Q30860069-F72043D3-D0E1-4924-A8F1-7DBADA1E9519

P356

P1433

P1476

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

@en

P2093

Alexander I Archakov

http://www.w3.org/2001/XMLSchema#string

Eugene I Goufman

http://www.w3.org/2001/XMLSchema#string

Irina N Taranets

http://www.w3.org/2001/XMLSchema#string

Oleg V Makarov

http://www.w3.org/2001/XMLSchema#string

Olga V Tikhonova

http://www.w3.org/2001/XMLSchema#string

Sergei A Moshkovskii

http://www.w3.org/2001/XMLSchema#string

Victor G Zgoda

http://www.w3.org/2001/XMLSchema#string

P304

3790-3797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.200401205

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Marina Serebryakova

Konstantin Kuteykin-Teplyakov

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7640005

http://www.w3.org/2001/XMLSchema#string

P698

16121334

http://www.w3.org/2001/XMLSchema#string

P921